HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"EN
14.12.2012 Official
Journal
of
the
European
Union L
342/27
COMMISSION IMPLEMENTING REGULATION (EU) No 1197/2012
of 13 December 2012
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval
periods of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ
10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium
catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim, methoxyfenozide, milbemectin,
phenmedipham, Pseudomonas chlororaphis Strain: MA 342, quinoxyfen, S-metolachlor, tepraloxydim,
thiacloprid, thiram and ziram
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
allow sufficient time to complete the renewal procedure
in accordance with that Regulation. Consequently, the
approval of those active substances would be likely to
expire before a decision has been taken on their renewal.
Having regard to the Treaty on the Functioning of the European
It is therefore necessary to postpone the expiry of their
Union,
approval periods.
Having regard to Regulation (EC) No 1107/2009 of the
European Parliament and of the Council of 21 October 2009
(3) Implementing
Regulation
(EU)
No
540/2011
should
concerning the placing of plant protection products on the
therefore be amended accordingly.
market and repealing Council Directives 79/117/EEC and
91/414/EEC ( 1 ), and in particular the first paragraph of
Article 17 thereof,
(4)
In view of the aim of the first paragraph of Article 17 of
Regulation (EC) No 1107/2009, as regards cases where
no supplementary dossier in accordance with Imple
Whereas:
menting Regulation (EU) No 844/2012 is submitted
within 30 months before the respective expiry date laid
down in the Annex to this Regulation, the Commission
will set the expiry date at the same date as before this
(1) Part
A
of
the
Annex
to
Commission
Implementing
Regu
Regulation or at the earliest date thereafter.
lation (EU) No 540/2011 of 25 May 2011 implementing
Regulation (EC) No 1107/2009 of the European
Parliament and of the Council as regards the list of
approved active substances
( 2 ) sets out the active
substances deemed to have been approved under Regu
(5)
In view of the aim of the first paragraph of Article 17 of
Regulation (EC) No 1107/2009, as regards cases where
lation (EC) No 1107/2009.
the Commission will adopt a Regulation providing that
the approval of an active substance referred to in the
Annex to this Regulation is not renewed because the
(2) The
approvals
of
the
active
substances
acetamiprid,
approval criteria are not satisfied, the Commission will
alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ
set the expiry date at the same date as before this Regu
10, benalaxyl, bifenazate, bromoxynil, chlorpropham,
lation or at the date of the adoption of the Regulation
desmedipham, etoxazole, Gliocladium catenulatum Strain:
providing that the approval of the active substance is not
J1446, imazosulfuron, laminarin, mepanipyrim, metho
renewed, whichever date is later.
xyfenozide, milbemectin, phenmedipham, Pseudomonas
chlororaphis Strain: MA 342, quinoxyfen, S-metolachlor,
tepraloxydim, thiacloprid, thiram and ziram will expire
between 31 July 2014 and 30 November 2015. Appli
(6) The
measures
provided
for
in
this
Regulation
are
in
cations have been submitted for the renewal of these
accordance with the opinion of the Standing
active substances. As the requirements laid down in
Committee on the Food Chain and Animal Health,
Commission Implementing Regulation (EU) No
844/2012 of 18 September 2012 setting out the
provisions necessary for the implementation of the
renewal procedure for active substances as provided for
HAS ADOPTED THIS REGULATION:
in Regulation (EC) No 1107/2009 of the European
Parliament and of the Council concerning the placing
of plant protection products on the market ( 3 ) will
apply to those active substances, it is necessary to
Article 1
Part A of the Annex to Implementing Regulation (EU) No
( 1 ) OJ L 309, 24.11.2009, p. 1.
( 2 ) OJ L 153, 11.6.2011, p. 1.
540/2011 is amended in accordance with the Annex to this
( 3 ) OJ L 252, 19.9.2012, p. 26.
Regulation.

---

L 342/28
EN
Official Journal of the European Union
14.12.2012
Article 2
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the
European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 13 December 2012.
For the Commission
The President
José Manuel BARROSO

---

EN
14.12.2012 Official
Journal
of
the
European
Union L
342/29
ANNEX
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) In the sixth column, expiration of approval, of entry 73, thiram, the date 31 July 2014 is replaced by 30 April
2017.
(2) In sixth column, expiration of approval, of entry 74, ziram, the date 31 July 2014 is replaced by 30 April 2017.
(3) In the sixth column, expiration of approval, of entry 82, quinoxyfen, the date 31 August 2014 is replaced by
30 April 2017.
(4) In the sixth column, expiration of approval, of entry 89, Pseudomonas chlororaphis Strain: MA 342, the date
30 September 2014 is replaced by 30 April 2017.
(5) In the sixth column, expiration of approval, of entry 90, mepanipyrim, the date 30 September 2014 is replaced by
30 April 2017.
(6) In the sixth column, expiration of approval, of entry 91, acetamiprid, the date 31 December 2014 is replaced by
30 April 2017.
(7) In the sixth column, expiration of approval, of entry 92, thiacloprid, the date 31 December 2014 is replaced by
30 April 2017.
(8) In the sixth column, expiration of approval, of entry 78, chlorpropham, the date 31 January 2015 is replaced by
31 July 2017.
(9) In the sixth column, expiration of approval, of entry 83, alpha-cypermethrin, the date 28 February 2015 is replaced
by 31 July 2017.
(10) In the sixth column, expiration of approval, of entry 84, benalaxyl, the date 28 February 2015 is replaced by 31 July
2017.
(11) In the sixth column, expiration of approval, of entry 85, bromoxynil, the date 28 February 2015 is replaced by
31 July 2017.
(12) In the sixth column, expiration of approval, of entry 86, desmedipham, the date 28 February 2015 is replaced by
31 July 2017.
(13) In the sixth column, expiration of approval, of entry 88, phenmedipham, the date 28 February 2015 is replaced by
31 July 2017.
(14) In the sixth column, expiration of approval, of entry 93, Ampelomyces quisqualis Strain: AQ 10, the date 31 March
2015 is replaced by 31 July 2017.
(15) In the sixth column, expiration of approval, of entry 94, imazosulfuron, the date 31 March 2015 is replaced by
31 July 2017.
(16) In the sixth column, expiration of approval, of entry 95, laminarin, the date 31 March 2015 is replaced by 31 July
2017.
(17) In the sixth column, expiration of approval, of entry 96, methoxyfenozide, the date 31 March 2015 is replaced by
31 July 2017.
(18) In the sixth column, expiration of approval, of entry 97, S-metolachlor, the date 31 March 2015 is replaced by
31 July 2017.
(19) In the sixth column, expiration of approval, of entry 98 Gliocladium catenulatum Strain: J1446, the date 31 March
2015 is replaced by 31 July 2017.
(20) In the sixth column, expiration of approval, of entry 99, etoxazole, the date 31 May 2015 is replaced by 31 July
2017.

---

L 342/30
EN
Official Journal of the European Union
14.12.2012
(21) In the sixth column, expiration of approval, of entry 100, tepraloxydim, the date 31 May 2015 is replaced by
31 July 2017.
(22) In the sixth column, expiration of approval, of entry 109, bifenazate, the date 30 November 2015 is replaced by
31 July 2017.
(23) In the sixth column, expiration of approval, of entry 110, milbemectin, the date 30 November 2015 is replaced by
31 July 2017.

---

Document Outline

• �

---